Recently Published Tests - Mayo Medical Laboratories

Rickettsia and Q Fever Antibody Panel, Serum

Tue, 07 Feb 2012 19:03:35 -0600

Test RICKQ/87812
Useful for: See Individual Unit Codes

Rickettsia Antibody Panel, Spotted Fever and Typhus Fever Groups, Serum

Tue, 07 Feb 2012 19:03:35 -0600

Test RICKS/84343
Useful for: To aid in the diagnosis of spotted fever group or typhus fever group rickettsial infections

Typhus Fever Group Antibody, IgG and IgM, Serum

Tue, 07 Feb 2012 19:03:13 -0600

Test TFGP/83678

Spotted Fever Group Antibody, IgG and IgM, Serum

Tue, 07 Feb 2012 19:03:13 -0600

Test SFGP/83679

PROMETHEUS TPMT Enzyme

Thu, 02 Feb 2012 19:03:40 -0600

Test FFTNZ/91596

Poliovirus (Types 1-3) Antibodies, CSF

Tue, 31 Jan 2012 19:01:20 -0600

Test FPLC/91343

Myelin Assoc. Glycoprotein (MAG) Antibody w/Reflex to MAG-SGPG & MAG, EIA

Mon, 23 Jan 2012 19:03:39 -0600

Test FMGA/57249

Ganglioside GQ1b Antibody IgG, EIA

Mon, 23 Jan 2012 19:03:38 -0600

Test FGQ1B/57248

Hu Antibody Titer and Western Blot

Mon, 23 Jan 2012 19:03:38 -0600

Test FHUTW/57247

Hu Antibody Screen with Reflex to Titer and Western Blot

Mon, 23 Jan 2012 19:03:38 -0600

Test FHUAB/57246

Anti-IgA

Mon, 09 Jan 2012 19:03:38 -0600

Test FAIGA/57251

Tissue Transglutaminase (tTG) Antibodies, IgA and IgG Profile, Serum

Fri, 16 Dec 2011 19:03:22 -0600

Test TSTGP/400004
Useful for: Evaluating patients suspected of having celiac disease, including patients with compatible clinical symptoms, patients with atypical symptoms, and individuals at increased risk (family history, previous diagnosis with associated disease, positivity for HLA DQ2 and/or DQ8)

Monitoring adherence to gluten-free diet in patients with dermatitis herpetiformis and celiac disease

Varicella-Zoster Antibody, IgG, Serum

Fri, 16 Dec 2011 19:00:44 -0600

Test VZSC/110202
Useful for: Determining the immune status of individuals to varicella-zoster virus

Tissue Transglutaminase (tTG) Antibody, IgG, Serum

Fri, 16 Dec 2011 19:00:43 -0600

Test TTGG/400006
Useful for: For individuals with IgA deficiency:
-Evaluating patients suspected of having celiac disease, including patients with compatible clinical symptoms, patients with atypical symptoms, and individuals at increased risk (family history, previous diagnosis with associated disorder, positivity for HLA DQ2 and/or DQ8
-Screening test for dermatitis herpetiformis, in conjunction with endomysial antibody test
-Monitoring adherence to gluten-free diet in patients with dermatitis herpetiformis and celiac disease

Tissue Transglutaminase (tTG) Antibody, IgA, Serum

Fri, 16 Dec 2011 19:00:43 -0600

Test TTGA/400005
Useful for: Evaluating patients suspected of having celiac disease, including patients with compatible clinical symptoms, patients with atypical symptoms, and individuals at increased risk (family history, previous diagnosis with associated disorder, positivity for HLA DQ2 and/or DQ8)

Screening test for dermatitis herpetiformis, in conjunction with endomysial antibody test

Monitoring adherence to gluten-free diet in patients with dermatitis herpetiformis and celiac disease

Lamellar Body Count, Amniotic Fluid

Thu, 15 Dec 2011 04:19:01 -0600

Test LBC/60450
Useful for: Predicting fetal lung maturity and assessing the risk of developing neonatal respiratory distress syndrome, when performed during 32 to 39 weeks gestation

Lamellar Body Count Reflex, Amniotic Fluid

Thu, 15 Dec 2011 04:19:01 -0600

Test LBCR/61179
Useful for: Predicting fetal lung maturity and assessing the risk of developing neonatal respiratory distress syndrome, when performed during 32 to 39 weeks gestation

Useful in cases in which lamellar body count results are indeterminate

Everolimus, Blood

Thu, 15 Dec 2011 04:17:00 -0600

Test EVERO/60537
Useful for: Management of everolimus immunosuppression in solid organ transplant

Ribavirin, Serum

Thu, 15 Dec 2011 04:16:17 -0600

Test RIBAV/60536
Useful for: Assessing adequacy of ribavirin therapy or potential drug-related toxicity

Leflunomide Metabolite (Teriflunomide), Serum

Thu, 15 Dec 2011 04:16:08 -0600

Test LEFLU/60292
Useful for: Therapeutic monitoring of patients actively taking leflunomide

Assessment of elimination in patients requiring enhanced elimination of the drug

Zinc/Creatinine Ratio, Random, Urine

Tue, 13 Dec 2011 04:18:26 -0600

Test ZNCRU/60527
Useful for: Identifying the cause of abnormal serum zinc concentrations

Vanadium/Creatinine Ratio, Random, Urine

Tue, 13 Dec 2011 04:18:23 -0600

Test VCRU/60575
Useful for: Detecting vanadium exposure

Thallium/Creatinine Ratio, Random, Urine

Tue, 13 Dec 2011 04:18:20 -0600

Test TLCRU/60325
Useful for: Detecting toxic thallium exposure

Selenium/Creatinine Ratio, Random, Urine

Tue, 13 Dec 2011 04:18:15 -0600

Test SECRU/60083
Useful for: Monitoring selenium replacement therapy

Lead/Creatinine Ratio, Random, Urine

Tue, 13 Dec 2011 04:18:04 -0600

Test PBCRU/60247
Useful for: Detecting clinically significant lead exposure.

Nickel/Creatinine Ratio, Random, Urine

Tue, 13 Dec 2011 04:18:01 -0600

Test NICRU/60442
Useful for: Urine nickel is the test of choice for detecting nickel toxicity in patients exposed to nickel carbonyl.

Manganese/Creatinine Ratio, Random, Urine

Tue, 13 Dec 2011 04:17:57 -0600

Test MNCRU/60027
Useful for: Monitoring manganese exposure

Nutritional monitoring

Clinical trials

Magnesium/Creatinine Ratio, Random, Urine

Tue, 13 Dec 2011 04:17:55 -0600

Test MGCRU/60244
Useful for: Assessing the cause of abnormal serum magnesium concentrations

Determining whether the body is receiving adequate nutrition

Iodine/Creatinine Ratio, Random, Urine

Tue, 13 Dec 2011 04:17:48 -0600

Test ICRU/60440
Useful for: Monitoring iodine excretion rate as an index of daily iodine replacement therapy

Correlating total body iodine load with (131)I uptake studies in assessing thyroid function

Gadolinium/Creatinine Ratio, Random, Urine

Tue, 13 Dec 2011 04:17:41 -0600

Test GDCRU/60428
Useful for: Diagnosis of nephrogenic systemic fibrosis by documenting gadolinium excretion in excess of that typical for the time duration following exposure to contrast media

Iron/Creatinine Ratio, Random, Urine

Tue, 13 Dec 2011 04:17:10 -0600

Test FECRU/60764
Useful for: Diagnosis of hemochromatosis, hemolytic anemia, paroxysmal nocturnal hemoglobinemia, and impaired biliary clearance

Copper/Creatinine Ratio, Random, Urine

Tue, 13 Dec 2011 04:16:51 -0600

Test CUCRU/60427
Useful for: Investigation of Wilson disease and obstructive liver disease

Cobalt/Creatinine Ratio, Random, Urine

Tue, 13 Dec 2011 04:16:49 -0600

Test COBCU/60353
Useful for: Detecting cobalt exposure

Monitoring metallic prosthetic implant wear

Arsenic/Creatinine Ratio, Random, Urine

Tue, 13 Dec 2011 04:16:39 -0600

Test ASCRU/89890
Useful for: Preferred screening test for detection of arsenic exposure

Osmolality, Serum

Mon, 12 Dec 2011 19:01:22 -0600

Test UOSMS/300540
Useful for: Evaluating acutely ill or comatose patients

Osmolality, Urine

Mon, 12 Dec 2011 19:00:44 -0600

Test UOSMU/300280
Useful for: Assessing the concentrating and diluting ability of the kidney

UDP-Glucuronosyl Transferase 1A1 (UGT1A1) Gene, Known Mutation, Saliva

Mon, 12 Dec 2011 04:18:22 -0600

Test UGTKO/60351
Useful for: Identifying the presence of a UGT1A1 mutation when the mutation has been identified in a family member (carrier or affected)

UDP-Glucuronosyl Transferase 1A1 (UGT1A1), Full Gene Sequencing, Irinotecan Hypersensitivity, Saliva

Mon, 12 Dec 2011 04:18:22 -0600

Test UGTIO/60349
Useful for: Identifying individuals who are at increased risk of adverse drug reactions with irinotecan and who should be considered for decreased dosing of the drug.

UDP-Glucuronosyl Transferase 1A1 (UGT1A1), Full Gene Sequencing, Hyperbilirubinemia, Saliva

Mon, 12 Dec 2011 04:18:22 -0600

Test UGT2O/60350
Useful for: Identifying individuals who are at risk of hyperbilirubinemia

Confirmation of a diagnosis of Gilbert or Crigler-Najjar syndromes

Verification of carrier status for Gilbert or Crigler-Najjar syndromes

UDP-Glucuronosyl Transferase 1A1 TA Repeat Genotype, UGT1A1, Saliva

Mon, 12 Dec 2011 04:18:22 -0600

Test U1A1O/60343
Useful for: Identifying individuals who are at increased risk of adverse drug reactions with irinotecan and who should be considered for decreased dosing of the drug.

Opioid Receptor, Mu 1 (OPRM1) Genotype for Naltrexone Efficacy, Saliva

Mon, 12 Dec 2011 04:18:03 -0600

Test OPRMO/60352
Useful for: Identifying individuals with a higher probability of successful treatment for alcoholism with naltrexone

N-Acetyltransferase 2 Gene (NAT2), Full Gene Sequence, Saliva

Mon, 12 Dec 2011 04:18:01 -0600

Test NAT2O/60345
Useful for: Identifying patients who may require isoniazid dosing adjustments

Serotonin Transporter Genotype, Saliva

Mon, 12 Dec 2011 04:17:48 -0600

Test HTTO/60339
Useful for: Qualifying participants for clinical trials

Evaluating patients who have failed therapy with selective serotonin reuptake inhibitors (SSRIs)

Evaluating patients with treatment-resistant depression

Predicting response time to improvement with SSRIs

Identifying patients who might respond favorably to nonselective antidepressants

Identifying patients who have diminished amounts of the serotonin transporter and, hence, an altered response to SSRI therapeutics

HLA-B 5701 Genotype, Abacavir Hypersensitivity, Saliva

Mon, 12 Dec 2011 04:17:46 -0600

Test HL57O/60347
Useful for: Predicting likelihood of hypersensitivity reactions to abacavir in HIV-infected patients, based on the presence of the HLA-B*5701 allele

Excluding HIV-infected patients from receiving abacavir therapy

Aiding in differentiating between true hypersensitivity to abacavir versus other underlying causes (eg, concomitant infection, reaction to other drugs, or inflammatory disease)

HLA-B 1502 Genotype, Carbamazepine Hypersensitivity, Saliva

Mon, 12 Dec 2011 04:17:46 -0600

Test HL15O/60348
Useful for: Identifying individuals of Asian ancestry who are at risk of developing Stevens-Johnson syndrome and toxic epidermal necrolysis when administered carbamazepine, phenytoin, or fosphenytoin therapy.

Dopamine Receptor D4 Genotype (DRD4), Saliva

Mon, 12 Dec 2011 04:16:55 -0600

Test DRD4O/60344
Useful for: Influencing the target dose of methylphenidate treatment for patients with attention deficit/hyperactivity disorder

Determining possible cause for poor response to methylphenidate in treated patients with attention deficit/hyperactivity disorder

Dopamine Receptor D3 Genotype, Saliva

Mon, 12 Dec 2011 04:16:54 -0600

Test DRD3O/60342
Useful for: Influencing choice of antipsychotics prior to treatment, especially to ascertain if atypical antipsychotics may be used with low risk of tardive dyskinesia

Identifying those patients receiving antipsychotics who are at increased risk of developing tardive dyskinesias. Individuals with the 25G allele should be monitored closely for signs of tardive dyskinesia if a decision is made to treat with antipsychotics

Testing may also be considered for individuals who will receive antipsychotic medications, if they are first-degree relatives of patients who have developed tardive dyskinesia.

Assessing potential for effective treatment response with clozapine, olanzapine, and risperidone

Catechol-O-Methyltransferase (COMT) Genotype, Saliva

Mon, 12 Dec 2011 04:16:50 -0600

Test COMTO/60336
Useful for: Early identification of patients who may show cognitive improvement with treatment for schizophrenia; this is associated with the *2/*2 genotype

Investigation of inhibitor dosing for decreasing L-dopa metabolism

Research use for assessing estrogen metabolism

Cytochrome P450 2D6 Genotype for Tamoxifen Hormonal Therapy, Saliva

Mon, 12 Dec 2011 04:16:34 -0600

Test 2D6TO/60340
Useful for: Determining the CYP2D6 genotype of patients considered for tamoxifen chemotherapy

Cytochrome P450 1A2 Genotype, Saliva

Mon, 12 Dec 2011 04:16:33 -0600

Test 1A2O/60346
Useful for: Identifying patients who are poor, intermediate, extensive, or ultrarapid metabolizers of drugs metabolized by CYP1A2

Adjusting dosages for drugs that are metabolized by CYP1A2

Warfarin Sensitivity Genotype by Sequence Analysis, Saliva

Wed, 07 Dec 2011 19:03:23 -0600

Test WARFO/60341
Useful for: Identifying patients who may require warfarin dosing adjustments (2,3) including:
-Patients who have previously been prescribed warfarin and have required multiple dosing adjustments to maintain the international normalized ratio in the target range.
-Patients with a history of thrombosis or bleeding when previously taking warfarin.
-Patients being started on a first prescription for warfarin

Cytochrome P450 2C19 Genotype by Sequence Analysis, Saliva

Wed, 07 Dec 2011 19:01:33 -0600

Test 2C19O/60335
Useful for: Identifying patients who are poor metabolizers or extensive metabolizers of drugs that are modified by CYP2C19

Evaluating individuals who have resistance to anticoagulation with clopidogrel

Cytochrome P450 2C9 Genotype by Sequence Analysis, Saliva

Wed, 07 Dec 2011 19:01:33 -0600

Test 2C9SO/60337
Useful for: Predicting metabolism status for drugs that are modified by CYP2C9

Evaluating patients for adverse drug reactions involving fluoxetine(1)

Assessing hypoglycemia with accepted dosing of oral hypoglycemic agents and sulfonylureas(2)

Assessing causes of idiosyncratic reactions to nonsteroidal anti-inflammatory drugs(3)

As an aid in altering dosing of antiepileptic drugs(4)

Tryptase, Autopsy

Tue, 06 Dec 2011 19:01:21 -0600

Test TRYPA/32283
Useful for: Assessing mast cell activation, which may occur as a result of anaphylaxis or allergen challenge

Assessing patients with systemic mastocytosis or mast cell activation syndrome

Monoclonal Protein Study, Random, Urine

Tue, 06 Dec 2011 04:18:09 -0600

Test RMPSU/60069
Useful for: Diagnosing monoclonal gammopathies

Electrophoresis, Protein, Random, Urine

Tue, 06 Dec 2011 04:18:08 -0600

Test REPU/60068
Useful for: Identifying patients with a monoclonal M-spike

Antinuclear Antibodies (ANA), HEp-2 Substrate, Serum

Mon, 05 Dec 2011 19:01:38 -0600

Test ANAH2/86038
Useful for: Diagnosis of autoimmune diseases

Amylase, Pancreatic Cyst

Fri, 02 Dec 2011 07:01:38 -0600

Test AMLPC/60078
Useful for: An aid in distinguishing between pseudocysts and other types of pancreatic cysts, when used in conjunction with imaging studies, cytology, and other pancreatic cyst fluid tumor markers

Serotonin Receptor Genotype (HTR2A and HTR2C), Saliva

Wed, 30 Nov 2011 19:02:47 -0600

Test HTR2O/60338
Useful for: Guiding treatment choice of an (selective serotonin reuptake inhibitor) SSRI or non-SSRI antidepressant. Individuals homozygous for the IVS2+54538 A allele have improved probability of response to citalopram, in contrast to individuals homozygous or heterozygous for the IVS2 G allele. Individuals with major depression disorders are more likely to respond to citalopram if they are homozygous for the -1438G promoter allele.

Guiding treatment choice in individuals who have a drug-metabolizer phenotype discordant with CYP450 genotypes

Identifying patients who may benefit from treatment with the antipsychotic drug clozapine

Identifying those patients receiving atypical antipsychotic medications with excessive weight gain who may benefit by switching to different antipsychotic medications

Cytochrome P450 2D6 Genotype, Saliva

Wed, 30 Nov 2011 19:01:34 -0600

Test 2D6O/60334
Useful for: Identifying patients who are poor or extensive metabolizers of antidepressant drugs metabolized by CYP2D6

Adjusting dosages for antidepressant drugs that are metabolized by CYP2D6

CLL Monitoring, MRD Detection FLIP, see #60490

Wed, 30 Nov 2011 19:01:13 -0600

Test PCLLM/20437
Useful for: Confirming the presence or absence of minimal residual disease in patients with known chronic lymphocytic leukemia who are either post-chemotherapy or post-bone marrow transplantation

Amoxicillin Level, BA

Thu, 24 Nov 2011 19:03:50 -0600

Test FMAXN/57245

Culture Referred for Identification, Mycobacterium

Thu, 17 Nov 2011 19:00:05 -0600

Test CTBID/80278
Useful for: Rapid identification of Mycobacterium, Nocardia, and other aerobic actinomycetes to the species level from pure cultures

Albumin Ratio

Thu, 17 Nov 2011 07:28:59 -0600

Test FZ004/33038

Borrelia Burgdorferi Antibody Index

Thu, 17 Nov 2011 07:28:59 -0600

Test FZ003/33037

Pyridoxic Acid (PA), Plasma

Thu, 17 Nov 2011 07:28:59 -0600

Test B6PA/61065

PDGFRB/TEL Translocation 5;12 for Chronic Myelomoncytic Leukemia (CMML), FISH

Thu, 17 Nov 2011 07:28:51 -0600

Test 19377

MYC, Chromogenic In Situ Hybridization (CISH)

Thu, 17 Nov 2011 07:28:50 -0600

Test 60076
Useful for: As an aid in diagnosing B-cell lymphomas

Microalbuminuria, 10-Hour Collection, Urine

Thu, 17 Nov 2011 07:28:40 -0600

Test 800109
Useful for: Evaluating diabetic patients to assess the potential for early onset
of nephropathy

Streptococcal Antibodies, Serum

Thu, 17 Nov 2011 07:28:38 -0600

Test 800073

Apolipoprotein B, Serum

Thu, 17 Nov 2011 07:28:32 -0600

Test APLBS/31087

Triglycerides, CDC, S

Thu, 17 Nov 2011 07:28:32 -0600

Test TRIGC/21090

Chronic Hept Scrn B

Thu, 17 Nov 2011 07:26:48 -0600

Test CHSBM/81387

Cryptococcus Antigen, Serum

Thu, 17 Nov 2011 07:26:14 -0600

Test SCRYR/28071
Useful for: Aiding in the diagnosis of cryptococcosis

Cryptococcus Antigen, Spinal Fluid

Thu, 17 Nov 2011 07:25:48 -0600

Test CCRYR/28072
Useful for: Aiding in the diagnosis of cryptococcosis

Viral Culture, Non-Respiratory